Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Histiocytosis
MeSH D015614 - histiocytosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008206:
Lymphatic diseases
0 Companies
0 Drugs
Success rate
D015614:
Histiocytosis
16 Companies
2 Drugs
$
Success rate
D006646:
Langerhans-cell histiocytosis
3 Companies
1 Drug
$
Success rate
D015616:
Non-langerhans-cell histiocytosis
0 Companies
0 Drugs
Success rate
D015620:
Malignant histiocytic disorders
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/1
Phase 3
67
%
2/3
Approved:
2
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Etoposide
Eli Lilly
Vinblastine
Bristol Myers Squibb
Etoposide
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use